Goldman Sachs
VANI icon

Goldman Sachs’s Vivani Medical VANI Stock Holding History

Goldman Sachs’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,423
Closed -$18.6K – 6663
2025
Q2 		$18.6K Buy
+14,423
New +$15.9K ﹤0.01% 5987
2022
Q4 		– Sell
-21,267
Closed -$48K – 6286
2022
Q3 		$48K Buy
21,267
+11,479
+117% +$54.5K ﹤0.01% 5804
2022
Q2 		$60K Sell
9,788
-2,031
-17% -$10.9K ﹤0.01% 5993
2022
Q1 		$51K Buy
11,819
+502
+4% +$2.11K ﹤0.01% 6270
2021
Q4 		$55K Buy
11,317
+3,091
+38% +$22.6K ﹤0.01% 6249
2021
Q3 		$79K Buy
+8,226
New +$92.6K ﹤0.01% 5954
2021
Q2 		– Sell
-4,384
Closed -$109K – 6536
2021
Q1 		$109K Buy
+4,384
New +$65.5K ﹤0.01% 5821
2019
Q4 		– Sell
-656
Closed -$13K – 5418
2019
Q3 		$13K Sell
656
-62
-9% -$1.22K ﹤0.01% 5121
2019
Q2 		$14K Sell
718
-363
-34% -$7.44K ﹤0.01% 5070
2019
Q1 		$21K Buy
1,081
+187
+21% +$3.64K ﹤0.01% 5049
2018
Q4 		$19K Sell
894
-363
-29% -$11.6K ﹤0.01% 5154
2018
Q3 		$57K Buy
1,257
+93
+8% +$3.75K ﹤0.01% 5268
2018
Q2 		$46K Sell
1,164
-10
-0.9% -$435 ﹤0.01% 5370
2018
Q1 		$54K Sell
1,174
-265
-18% -$11.8K ﹤0.01% 5458
2017
Q4 		$66K Buy
1,439
+347
+32% +$11.5K ﹤0.01% 5873
2017
Q3 		$31K Sell
1,092
-1,874
-63% -$52.4K ﹤0.01% 6360
2017
Q2 		$90K Buy
2,966
+2,419
+442% +$68.4K ﹤0.01% 6163
2017
Q1 		$16K Buy
+547
New +$21K ﹤0.01% 6560
2016
Q3 		– Sell
-5,021
Closed -$431K – 7198
2016
Q2 		$431K Buy
5,021
+2,148
+75% +$224K ﹤0.01% 4987
2016
Q1 		$333K Buy
2,873
+1,450
+102% +$167K ﹤0.01% 5165
2015
Q4 		$201K Sell
1,423
-2,322
-62% -$340K ﹤0.01% 5709
2015
Q3 		$533K Buy
3,745
+2,697
+257% +$749K ﹤0.01% 5078
2015
Q2 		$342K Sell
1,048
-494
-32% -$158K ﹤0.01% 5608
2015
Q1 		$474K Sell
1,542
-578
-27% -$161K ﹤0.01% 5188
2014
Q4 		$522K Buy
+2,120
New +$739K ﹤0.01% 5240

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's VANI Position: Q3 2025 in Review

Goldman Sachs sold out of Vivani Medical (VANI) in Q3 2025, closing a stake of 14,423 shares — an estimated $18.6K sold.

Goldman Sachs first reported a position in VANI in Q4 2014 and held it in 25 quarters. The position peaked at $533K in Q3 2015. 29 funds tracked by Wall St. Rank hold VANI as of Q3 2025.

  • Goldman Sachs reported no remaining Vivani Medical position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 14,423 Vivani Medical shares in Q3 2025, an estimated $18.6K.
  • Goldman Sachs first reported a position in Vivani Medical in Q4 2014 and held it in 25 quarters.
  • Goldman Sachs's Vivani Medical position peaked at $533K in Q3 2015.
  • 29 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.